Elucidation of mechanism underlying acquisition of specificity for ATP

Fig.1:Structure of ATP and poly(P).

The mechanism underlying the acquisition of specificity for ATP has been elucidated by researchers in a new report published in Scientific Reports on September 11th, 2013.

Inorganic polyphosphate [poly(P)], a polymer of orthophosphate (Pi) residues linked by high-energy phosphoanhydride bonds, is found in every organism from bacteria to animals (Fig.1). ATP is a universal energy carrier, sometimes termed the "energy currency" of cells (Fig.1). NAD kinase (NADK) catalyzes the phosphorylation of NAD+ to yield NADP+, using poly(P) or ATP as a source of phosphate and energy. poly(P)/ATP-NADK utilizes both poly(P) and ATP, whereas ATP-specific NADK prefers ATP to poly(P).

The group have assumed that NADKs evolved from poly(P)/ATP-NADKs into ATP-specific NADKs, and that recently diverged organisms obtained ATP-specific NADKs during their evolution, based on the following observations: (i) it has been deduced that bacteria evolved from Gram-positive bacteria or Archaea into Gram-negative ?-proteobacteria; (ii) poly(P)/ATP-NADKs are distributed throughout Gram-positive bacteria and Archaea, whereas ATP-specific NADKs are found in Gram-negative ?-proteobacteria (Escherichia coli and Salmonella enterica) and eukaryotes. However, it remains unclear how NADKs evolved from poly(P)/ATP-NADKs into ATP-specific NADKs.

Fig.2:Almost all γ-proteobacterial ATP-specific NADKs carrying the GGDGN motif are further concentrated within the most recently diverged group within γ-proteobacteria. It has been deduced that bacteria evolved from Gram-positive bacteria or Archaea into Gram-negative γ-proteobacteria, within which Salmonella, Shigella, Yersinia, and Vibrio etc. constitute the most recently diverged group. The ATP-specific NADKs in this most recently diverged group carry the GGDGN motif.

In this study, we succeeded in conferring the ability to utilize poly(P) on ?-proteobacterial ATP-specific NADKs, and hence in the effective "reversion" of these NADKs, through a single amino-acid substitution: substitution of Asn to Thr in the GGDGN motif that is conserved in the ?-proteobacterial ATP-specific NADKs. As a result of this substitution, the poly(P)-dependent NADK activity of E. coli ATP-specific NADK dramatically increased, from 2.8? to 43? (the relative activity to the 100? ATP-dependent activity). These data indicate that NADK has lost the ability to utilize poly(P), and that it acquired its specificity for ATP over the course of evolution as a result of the change from Thr to Asn in the GGDGT motif conserved among NADKs from almost all organisms.

Remarkably, almost all ?-proteobacterial NADKs carrying the GGDGN motif are further concentrated within the most recently diverged group within ?-proteobacteria, which includes E. coli and other pathogenic bacteria (Salmonella, Shigella, Yersinia, Vibrio, etc.) (Fig.2). Therefore, we propose that NADKs evolved from poly(P)/ATP-NADKs (carrying GGDGT) via Gram-negative ?-proteobacterial poly(P)/ATP-NADKs (carrying GGDGS) into Gram-negative ?-proteobacterial ATP-specific NADKs (carrying GGDGN) (Fig.2), as also depicted in Fig.3. It should be noted that human NADK carries the GGDGT motif, although this enzyme is ATP-specific, indicating that the mechanism underlying the acquisition of specificity for ATP (i.e., the structural determinants conferring specificity for ATP) differs between human ATP-specific NADK and ?-proteobacterial ATP-specific NADKs.

The group have established methods for large-scale production of NADP+, which is used in the diagnostic pharmaceutical industry, by utilizing poly(P)/ATP-NADK (Patent: 4088251 JAPAN). However, we have shown that the poly(P)/ATP-NADK created through the method described here exhibits higher poly(P)-dependent activity, and is therefore more suitable for poly(P)-dependent mass production of NADP+, than the poly(P)/ATP-NADK the group used originally.

Fig.3:The proposed evolution of bacterial NADK from poly(P)/ATP-NADK into γ-proteobacterial ATP-specific NADK. The group propose that bacterial NADKs evolved as depicted here. Thus, the biotechnological conversion of ATP-specific NADK into poly(P)/ATP-NADK is in effect the "reversion" of ATP-specific NADK.

Because the structural determinants conferring specificity to ATP differ between human ATP-specific NADK and ?-proteobacterial ATP-specific NADKs, it might be possible to develop new antibiotics that specifically target ?-proteobacterial ATP-specific NADKs, but not human ATP-specific NADK. This study also provides a significant clue regarding how NADKs recognize and utilize poly(P). This information opens the way to development of a novel system for production of valuable compounds, in which the ability to utilize poly(P) would be conferred on various ATP-specific enzymes, and the resultant poly(P)-dependent enzymes could then be utilized to produce various phosphoryl compounds using poly(P) instead of ATP. Finally, this study provides significant hints regarding why poly(P)/ATP-NADK has evolved into ATP-specific NADK, what the physiological significance of this evolution is, and what the relationship of this evolution with the properties (pathogenicity, etc.) of each bacterium is.

More information: Yusuke, N. et al. Conferring the ability to utilize inorganic polyphosphate on ATP-specific NAD kinase, Scientific Reports 3, 2632. DOI: 10.1038/srep02632 (2013)

add to favorites email to friend print save as pdf

Related Stories

A better trigger for targeted drug delivery

Aug 09, 2013

Biomolecular 'nanocarriers' formed by the careful assembly of protein subunits are common in nature and perform a range of essential roles in biological processes, powered by the biological energy carrier ...

Random walks on DNA

Apr 19, 2013

Scientists have revealed how a bacterial enzyme has evolved an energy-efficient method to move long distances along DNA. The findings, published in Science, present further insight into the coupling of chemical and mechan ...

Recommended for you

Organovo has 3D-printed liver tissue for drug testing

Nov 20, 2014

(Medical Xpress)—The commercial release of 3D printed liver tissue was announced earlier this week. Organovo is the company behind the release. The product is intended for use for preclinical drug discovery ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.